Analyst Price Target is GBX 0
This price target is based on 0 analysts offering 12 month price targets for AorTech International in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a NaN upside from the last price of GBX 0.
Current Consensus is
N/A
The current consensus among 0 polled investment analysts is to n/a stock in AorTech International. This N/A consensus rating has held steady for over two years.
AorTech International
AorTech International plc, together with its subsidiaries, focuses on the commercialization of its biomedical polymer technology, components, and medical devices in the United Kingdom. The company offers Elast-Eon, a bio stable polyurethane material used in long term implantation; and Elast-Eon Carbonate Silicone, a family of biomedical polymers for applications in cardiac pacing leads, orthopedics, and spinal discs, as well as in other applications where the device requires a high level of mechanical performance. It also provides Elast-Eon Reaction Injection Molding products for use in high-precision medical device components. In addition, the company licenses its technology; and offers support services to other medical device companies. AorTech International plc was incorporated in 1996 and is headquartered in Weybridge, the United Kingdom.
Read More
